17 results
Pathogenesis of Diabetic Ketoacidosis - Insulin deficiency or severe insulin insensitivity 

#DKA #Pathophysiology #Endocrinology #Diabetes #Ketoacidosis
Pathogenesis of Diabetic ... insensitivity #DKA ... #Pathophysiology ... #Endocrinology ... #Diabetic
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... (DKA) and Hyperglycemic ... Polydipsia #dka ... #hhs #pathophysiology ... #comparison #endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... of carbohydrate metabolism ... state and fat metabolism ... #DKA #Diabetes ... #Endocrinology
Pathophysiology and Effects of Insulin Deficiency

#Insulin #Deficiency #DKA #Ketoacidosis #Diabetes #Pathophysiology #Endocrinology
Pathophysiology ... Insulin #Deficiency #DKA ... #Ketoacidosis #Diabetes ... #Pathophysiology ... #Endocrinology
Stages in the Development of Diabetes Type 1

#Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
Development of Diabetes ... Type 1 #Diabetes ... #Type1 #TypeI #DM1 ... #Development #Pathophysiology ... Timeline #Diagnosis #Endocrinology
Hyperglycemic Crisis - Algorithm for DKA/HHS

Diagnostic criteria for DKA:
 • pH < 7.3
 • Anion gap
Algorithm for DKA ... Diagnostic criteria for DKA ... MatthewHoMD #DKA ... Algorithm #management #endocrinology ... #Diabetes #DM2
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
bodies are a normal metabolic ... fatty acid (FA) metabolism ... • Diabetic ketoacidosis ... (DKA) - caused ... diagnosis #management #endocrinology
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings
 • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... Due to neuronal metabolism ... #pathophysiology ... #endocrinology ... #diabetes
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
mL/minute/1.73 m2 ... • Euglycemic diabetic ... ketoacidosis (DKA ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Understanding the pathophysiology of hyperglycemia

#DKA #Diabetic #Ketoacidosis #Endocrinology #Pathophysiology
Understanding the pathophysiology ... hyperglycemia #DKA ... #Diabetic #Ketoacidosis ... #Endocrinology ... #Pathophysiology